Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

ZAMBIA: Zambia Introduces Rationing System for Drugs to Treat HIV




 

Thomson Reuters Foundation (08.21.2013)

A Zambian government antiretroviral (ARV) drug rationing system has alarmed HIV-infected residents who fear treatment interruptions. Although First Lady Dr. Christine Kaseba Sata acknowledged an ARV shortage in Zambia, Dr. Kamoto Mbewe, spokesperson for the Zambian Ministry of Health, asserted that Matero and Chingwere clinics in Lusaka did have a one-month supply of Atripla, the single-dose ARV, and would receive another shipment “soon.” Mbewe urged HIV-infected people not to panic, as existing ARV supplies were sufficient to last until expected shipments arrived in August and September. Pending shipments would include 55,260 bottles of Abacavir and 491,000 bottles of Truvada. Since January, the Zambian government has spent more than $16 million on “essential drugs,” including ARVs. Zambian Ministry of Health plans called for all HIV-infected Zambians to transition eventually to the single-dose Atripla regimen. Lloyd Nkumbula Bwalya, district coordinator for the Network of Zambian People Living with HIV/AIDS, feared that difficulties imposed by the rationing system—daily queuing for drugs and delays in service—would result in HIV patients missing scheduled ARV doses. Zambia’s Minister of Health affirmed in a mid-year media briefing that maintaining an uninterrupted ARV supply for every HIV-infected Zambian was a priority.



 


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in August 22, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.